Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

Name: Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).
Author: Namikawa, Kenjiro

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON). — المؤلف: Namikawa, Kenjiro — Japanese journal of clinical oncology 20180223

المؤلف: Namikawa, Kenjiro
النشر: Japanese journal of clinical oncology 20180223
الوصف: 664-667 p.
الموضوعات: Chemotherapy, Adjuvant؛ Combined Modality Therapy؛ Disease-Free Survival؛ Humans؛ Interferon-beta؛ Japan؛ Medical Oncology؛ Melanoma